Internal flow testing of the XEN gel Micro Invasive Glaucoma Stent had failed to achieve consistent results. Aquesys was approaching a committed FDA submission deadline.
Based upon years of experience with the design and testing of micro fluidic ophthalmic devices , Xinetix was engaged to perform fluidic of the XEN Gel MIGS device. Xinetix completed testing and produced a test report which resulted in successful FDA clearance to market the XEN device.
